Exactech, Inc.: FDA filings under this applicant name
FDA lists 186 510(k) clearances under the applicant name “Exactech, Inc.” (first 1986, latest 2026), plus 1 PMA decision, across 40 product codes in 2 review panels. Median 510(k) review time under this name: 86 days. Since 2017 the median was 134 days, against 100 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 8 | 122 |
| 2013 | 8 | 99 |
| 2014 | 8 | 105 |
| 2015 | 9 | 107 |
| 2016 | 6 | 103 |
| 2017 | 6 | 129 |
| 2018 | 8 | 88 |
| 2019 | 4 | 150 |
| 2020 | 2 | 186 |
| 2021 | 0 | — |
| 2022 | 1 | 218 |
| 2023 | 6 | 268 |
| 2024 | 2 | 252 |
| 2025 | 4 | 260 |
| 2026 | 1 | 53 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Exactech, Inc. took a median 134 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 100 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JWH | Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer | 32 | 32 |
| LZO | Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented | 21 | 21 |
| PHX | Shoulder Prosthesis, Reverse Configuration | 21 | 21 |
| LPH | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented | 19 | 19 |
| JDI | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented | 12 | 12 |
| KWS | Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented | 8 | 8 |
| MEH | Prosthesis, Hip, Semi-Constrained, Uncemented, Metal / Polymer, Non-Porous, Calcium Phosphate | 8 | 8 |
| LOD | Bone Cement | 5 | 5 |
| MBH | Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer | 5 | 5 |
| HSD | Prosthesis, Shoulder, Hemi-, Humeral, Metallic Uncemented | 4 | 4 |
Plus 30 more product codes.
Review panels
- Orthopedic (185)
- Dental (1)
Most recent Exactech, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K260583 | Equinoxe® Shoulder System | PHX | 2026-04-14 | 53 |
| K250713 | Equinoxe® Humeral Reconstruction Prosthesis; Equinoxe® Stemless Shoulder Implants | KWT | 2025-12-01 | 266 |
| K243448 | Equinoxe® Shoulder System | PHX | 2025-08-01 | 267 |
| K243275 | Equinoxe® Scapula Fracture System | HRS | 2025-06-26 | 253 |
| K243839 | Alteon® HA Femoral Stems | MEH | 2025-03-10 | 87 |
| K240393 | Exactech® TRULIANT® Knee System | MBH | 2024-10-03 | 238 |
| K233482 | Equinoxe® Central Screw Baseplate System | PHX | 2024-07-18 | 266 |
| K230717 | Exactech® Vantage® Total Ankle System | HSN | 2023-10-12 | 211 |
| K223933 | Exactech Equinoxe PHx Fracture System; Exactech EPIC Screws | HRS | 2023-09-25 | 269 |
| K223833 | Exactech® Equinoxe® Reverse Humeral Liners and Humeral Adapter Trays | PHX | 2023-09-14 | 266 |
176 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P050039 | PMA | NOVATION CERAMIC ARTICULATION HIP SYSTEM | 2007-07-05 |
Recalls
221 product recalls in 71 recall events; 63 initiated in the last five years. Most recent: 2026-02-03.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Exactech, Inc. is the lead sponsor of 7 device studies on ClinicalTrials.gov (5 active or recruiting). Most recent:
- NCT07107581: Exactech Knee Systems Post Market Clinical Follow-up (Enrolling by invitation, started 2023-12-01)
- NCT05849961: Exactech Hip Systems Post-Market Clinical Follow-up (PMCF) (Recruiting, started 2023-10-13)
- NCT05516381: Evaluation of Navigation-Assisted TKA Using Mechanical vs. Restricted Kinematic Alignment (Recruiting, started 2023-05-15)
- NCT05653102: A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System (Recruiting, started 2019-01-23)
- NCT05788757: Optetrak Knee System Post Market Clinical Follow-Up (Active not recruiting, started 2011-06-01)
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Exactech, Inc. (a text match, not an official crosswalk):
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Exactech Sarasota (2 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Exactech, Inc.?
FDA lists 186 510(k) clearances under the applicant name “Exactech, Inc.” (first 1986, latest 2026), plus 1 PMA decision, across 40 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Exactech, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Exactech, Inc. is 86 days. Since 2017: 134 days, versus 100 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Exactech, Inc.?
The most frequent FDA product codes under this applicant name are JWH (Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer, 32); LZO (Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented, 21); PHX (Shoulder Prosthesis, Reverse Configuration, 21).
Next steps
- See all 186 Exactech, Inc. clearances with predicates and recalls
- Run predicate analysis for product code JWH, Exactech, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.